Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership(A) | 2024-04-12 4:11 pm | N/A N/A | Traws Pharma Inc. | TRAW | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC See Remarks | 0 | $0 | 31,961,744 (Indirect) | View |
Ownership(A) | 2024-04-11 5:41 pm | N/A N/A | Traws Pharma Inc. | TRAW | TPAV LLC 10% Owner | 0 | $0 | 37,775,701 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:07 pm | N/A N/A | Traws Pharma Inc. | TRAW | Redfield Robert Acting Chief Medical Officer | 97,500 | $0 | 97,500 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:04 pm | 2023-11-01 2033-10-31 | Traws Pharma Inc. | TRAW | Pauza Charles David Chief Science Officer Virology | 933,863 | $0 | 933,863 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:03 pm | N/A N/A | Traws Pharma Inc. | TRAW | CAUTREELS WERNER Chief Executive Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:01 pm | 2023-11-01 2033-10-31 | Traws Pharma Inc. | TRAW | Savchuk Nikolay Chief Operating Officer | 6,475,339 | $0 | 5,589,757 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 7:59 pm | 2023-11-01 2033-10-31 | Traws Pharma Inc. | TRAW | Dukes Iain D. Executive Chairman | 5,587,223 | $0 | 5,587,173 (Direct) | View |
Ownership | 2024-04-03 7:57 pm | N/A N/A | Traws Pharma Inc. | TRAW | Viriom Inc. 10% Owner | 0 | $0 | 49,656,244 (Direct) | View |
Ownership | 2024-04-03 7:56 pm | N/A N/A | Traws Pharma Inc. | TRAW | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC 10% Owner | 0 | $0 | 26,729,195 (Indirect) | View |
Ownership | 2024-04-03 7:51 pm | N/A N/A | Traws Pharma Inc. | TRAW | TPAV LLC 10% Owner | 0 | $0 | 26,729,195 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 5:40 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 8,666 | $0 | 53,310 (Direct) | View |
| 2024-03-14 Tax Withholding | 2024-03-15 5:40 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 2,591 | $0.9 | 53,310 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 5:36 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | 23,111 | $0 | 121,014 (Direct) | View |
| 2024-03-14 Tax Withholding | 2024-03-15 5:36 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | 8,727 | $0.9 | 121,014 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:38 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 6,900 | $0 | 36,801 (Direct) | View |
| 2024-02-07 Tax Withholding | 2024-02-09 5:38 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 2,443 | $0.67 | 36,801 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:36 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | 21,320 | $0 | 81,728 (Direct) | View |
| 2024-02-07 Tax Withholding | 2024-02-09 5:36 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | 9,212 | $0.67 | 81,728 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-27 4:41 pm | N/A 2033-10-02 | Onconova Therapeutics Inc. | ONTX | Moyo Victor M CHIEF MEDICAL OFFICER | 125,000 | $0 | 125,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 5:53 pm | 2024-08-10 2033-08-10 | Onconova Therapeutics Inc. | ONTX | Shoemaker Mary Teresa Director | 66,468 | $0 | 66,468 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 5:52 pm | 2024-08-10 2033-08-10 | Onconova Therapeutics Inc. | ONTX | STOVER JACK E Director | 66,468 | $0 | 66,468 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 5:49 pm | 2024-08-10 2033-08-10 | Onconova Therapeutics Inc. | ONTX | Atadja Peter Director | 66,468 | $0 | 66,468 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 5:47 pm | 2024-08-10 2033-08-10 | Onconova Therapeutics Inc. | ONTX | Clarke Trafford Director | 66,468 | $0 | 66,468 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 5:45 pm | 2024-08-10 2033-08-10 | Onconova Therapeutics Inc. | ONTX | MEHTA VIREN Director | 66,468 | $0 | 66,468 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 5:43 pm | 2024-08-10 2033-08-10 | Onconova Therapeutics Inc. | ONTX | GROOPMAN JEROME Director | 66,468 | $0 | 66,468 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 5:41 pm | 2024-08-10 2033-08-10 | Onconova Therapeutics Inc. | ONTX | MARINO JAMES J Director | 66,468 | $0 | 66,468 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 4:45 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 4,750 | $0 | 30,194 (Direct) | View |
| 2023-08-03 Tax Withholding | 2023-08-04 4:45 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 1,422 | $1.02 | 30,194 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 4:42 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | 12,567 | $0 | 60,867 (Direct) | View |
| 2023-08-03 Tax Withholding | 2023-08-04 4:42 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | 4,744 | $1.01 | 60,867 (Direct) | View |
| 2023-06-12 Exercise | 2023-06-13 4:54 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 5,500 | $0 | 33,116 (Direct) | View |
| 2023-06-12 Tax Withholding | 2023-06-13 4:54 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 1,575 | $1.137 | 33,116 (Direct) | View |
| 2023-03-13 Option Award | 2023-03-14 7:19 pm | N/A 2033-03-13 | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-03-13 Option Award | 2023-03-14 6:48 pm | N/A 2033-03-13 | Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | 276,333 | $0 | 276,333 (Direct) | View |
| 2023-03-13 Option Award | 2023-03-14 6:46 pm | N/A 2033-03-13 | Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD CHIEF MEDICAL OFFICER | 82,667 | $0 | 82,667 (Direct) | View |
| 2023-02-07 Exercise | 2023-02-08 6:00 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | 21,320 | $0 | 83,117 (Direct) | View |
| 2023-02-07 Tax Withholding | 2023-02-08 6:00 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | 6,977 | $1.36 | 83,117 (Direct) | View |
| 2023-02-07 Exercise | 2023-02-08 5:58 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD CHIEF MEDICAL OFFICER | 5,833 | $0 | 22,154 (Direct) | View |
| 2023-02-07 Tax Withholding | 2023-02-08 5:58 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD CHIEF MEDICAL OFFICER | 1,242 | $1.36 | 22,154 (Direct) | View |
| 2023-02-07 Exercise | 2023-02-08 5:56 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 6,900 | $0 | 31,991 (Direct) | View |
| 2023-02-07 Tax Withholding | 2023-02-08 5:56 pm | N/A N/A | Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO | 1,785 | $1.36 | 31,991 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 6:59 pm | N/A 2032-12-15 | Onconova Therapeutics Inc. | ONTX | Clarke Trafford Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 6:56 pm | N/A 2032-12-15 | Onconova Therapeutics Inc. | ONTX | Atadja Peter Director | 100,000 | $0 | 100,000 (Direct) | View |